Covenant Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-6,484
| Closed | -$3.5M | – | 145 |
|
2024
Q1 | $3.5M | Buy |
6,484
+98
| +2% | +$52.9K | 0.57% | 40 |
|
2023
Q4 | $3.54M | Sell |
6,386
-230
| -3% | -$128K | 0.64% | 36 |
|
2023
Q3 | $2.89M | Sell |
6,616
-15
| -0.2% | -$6.56K | 0.76% | 41 |
|
2023
Q2 | $3.33M | Buy |
6,631
+3,127
| +89% | +$1.57M | 0.85% | 39 |
|
2023
Q1 | $1.75M | Buy |
3,504
+111
| +3% | +$55.5K | 0.42% | 59 |
|
2022
Q4 | $1.38M | Sell |
3,393
-27
| -0.8% | -$11K | 0.33% | 67 |
|
2022
Q3 | $1.11M | Sell |
3,420
-3,670
| -52% | -$1.2M | 0.32% | 66 |
|
2022
Q2 | $2.49M | Sell |
7,090
-175
| -2% | -$61.4K | 0.79% | 36 |
|
2022
Q1 | $3.97M | Sell |
7,265
-6
| -0.1% | -$3.28K | 1.07% | 23 |
|
2021
Q4 | $4.79M | Buy |
7,271
+297
| +4% | +$196K | 1.27% | 23 |
|
2021
Q3 | $4.34M | Buy |
6,974
+79
| +1% | +$49.1K | 1.29% | 22 |
|
2021
Q2 | $4.36M | Sell |
6,895
-35
| -0.5% | -$22.1K | 1.3% | 23 |
|
2021
Q1 | $3.39M | Buy |
6,930
+170
| +3% | +$83.2K | 1.06% | 31 |
|
2020
Q4 | $3.38M | Buy |
6,760
+235
| +4% | +$117K | 1.11% | 27 |
|
2020
Q3 | $2.57M | Sell |
6,525
-178
| -3% | -$70K | 0.82% | 29 |
|
2020
Q2 | $2.21M | Sell |
6,703
-72
| -1% | -$23.8K | 0.49% | 36 |
|
2020
Q1 | $1.64M | Buy |
6,775
+96
| +1% | +$23.3K | 0.5% | 38 |
|
2019
Q4 | $1.74M | Buy |
6,679
+99
| +2% | +$25.9K | 0.76% | 44 |
|
2019
Q3 | $1.79M | Buy |
6,580
+145
| +2% | +$39.4K | 0.9% | 39 |
|
2019
Q2 | $1.77M | Buy |
6,435
+355
| +6% | +$97.8K | 0.92% | 38 |
|
2019
Q1 | $1.36M | Buy |
+6,080
| New | +$1.36M | 0.71% | 48 |
|